Vidur Human Care Pvt. Ltd. is expanding its existing pharmaceutical formulation unit at Plot No. 3A, Sy. No. 542, Shapoorji Pallonji Biotechnology Park, Kolthur village, Shamirpet mandal, Medchal-Malkajgiri district, Telangana, at a project cost of Rs.490 million, over and above the existing project cost of Rs.655 million. Under the expansion, several earlier-approved product lines including Amlodipine, Digoxin, Erythromycin, Finasteride, Etravirine, Atazanavir, Tipranavir and Galantamine formulations have been dropped, while a fresh basket of 30 oral solid dosage products—including tablets and capsules of Theophylline, Metformin, Venlafaxine, Carbamazepine, Apixaban, Bilastine, Lacosamide, Escitalopram and other formulations—has been proposed, each at a capacity of 40 million units per annum. The State Pollution Control Board granted Consent for Establishment for the expansion under the Water (Prevention and Control of Pollution) Act, 1974 and the Air (Prevention and Control of Pollution) Act, 1981, after inspection of the site by the Regional Office, Medchal. The facility is expected to be equipped with tablet compression and capsule filling lines, coating machines, blending and granulation equipment, a coal-fired boiler with cyclone dust collector and wet scrubber for air pollution control, an effluent treatment plant with MGF, softener, RO and UV disinfection systems, and hazardous waste storage and disposal arrangements, along with a Digital Environmental Display Board and rainwater harvesting structures as mandated by the Board. The proponent is required to obtain Consent for Operation from the Board prior to commencement of the expanded activity.